Spina bifida is a neural tube defect in which the developing spinal cord and surrounding tissues fail to close completely. The most severe open form, myelomeningocele, can cause lower-limb weakness, sensory impairment, bladder and bowel dysfunction, hydrocephalus, and Chiari II malformation. Fetal surgery aims to reduce some of the damage that develops before birth rather than repair every consequence after delivery.
The modern evidence base began with the Management of Myelomeningocele Study, commonly known as MOMS. That randomized trial showed meaningful benefits from prenatal repair in carefully selected pregnancies, while also demonstrating significant maternal and obstetric risks. Since then, treatment has expanded through open hysterotomy, fetoscopic repair, and highly specialized multidisciplinary programs.
The subject remains closely tied to perinatal medicine, fetal imaging, neonatal neurosurgery, and long-term developmental follow-up. Archived congress resources, including the FAOPS 2020 archive, reflect the international clinical and research setting in which advances in fetal and neonatal care have been discussed.
In open spina bifida, exposed neural tissue is vulnerable to direct trauma from the uterine environment and to progressive injury caused by contact with amniotic fluid. The fetal surgery concept is therefore protective: closing the defect before birth may preserve functioning neural tissue and limit the downward displacement of the hindbrain.
The strongest demonstrated benefits concern hydrocephalus and hindbrain herniation. In the MOMS trial, prenatal repair reduced the need for cerebrospinal fluid shunting by 12 months and improved reversal of hindbrain herniation at birth. Children who underwent fetal repair also showed better early motor outcomes than those treated after delivery, although the degree of benefit varied substantially.
Fetal closure does not restore spinal cord tissue that is already damaged. A lesion’s anatomical level, ventricular size, lower-limb movement, associated abnormalities, and evolving neurological findings still influence prognosis. Families should understand that surgery changes probabilities; it does not guarantee independent walking, normal bladder function, or freedom from future neurosurgical care.
The MOMS trial remains the reference point for counseling. Prenatal repair was associated with a lower rate of shunt placement and better composite motor outcomes at 30 months. Follow-up into school age suggested sustained advantages in mobility and some functional domains, though differences were less dramatic than the original short-term findings and were affected by rehabilitation, family resources, and selection factors.
The maternal trade-off was substantial. Open fetal surgery increased the risk of preterm birth, uterine scar complications, placental abnormalities, and the need for cesarean delivery in the current and future pregnancies. Premature delivery remains one of the most important threats to a favorable outcome because neurological and respiratory complications can offset the expected benefit of lesion closure.
| Outcome domain | Prenatal repair | Postnatal repair |
|---|---|---|
| Hindbrain herniation | More frequent reversal before birth | Usually persists until after neonatal repair |
| Cerebrospinal fluid shunt | Lower probability in eligible patients | Higher probability in historical trial populations |
| Early motor function | Improved average motor outcomes | Lower average outcomes in comparable groups |
| Prematurity | Greater risk, including very early delivery | Usually lower procedure-related prematurity risk |
| Maternal effects | Uterine incision, scar, and placental risks | Avoids fetal hysterotomy and its associated risks |
| Long-term independence | Variable; lesion level remains decisive | Variable; requires lifelong multidisciplinary care |
Later programs have reported encouraging results with fetoscopic closure, including less invasive maternal access and the possibility of reducing some uterine-scar consequences. However, techniques, patient selection, surgical expertise, and definitions of success differ between centers. Fetoscopic repair should not be treated as automatically equivalent to the results of the randomized open-surgery trial.
Eligibility is usually determined by a fetal care team rather than by a single scan or consultation. Common criteria include a confirmed open myelomeningocele, a lesion within a defined spinal range, evidence of hindbrain herniation, an appropriate gestational age, and the absence of major chromosomal, structural, or maternal contraindications. Exact requirements vary by program and surgical approach.
Detailed ultrasound and fetal MRI help define the defect, ventricular dimensions, hindbrain position, limb movement, and associated anomalies. Maternal assessment includes uterine anatomy, prior surgical history, general health, obstetric risk, and the ability to remain near the treatment center for weeks after surgery. Genetic counseling may be offered when imaging or family history raises concern about an underlying condition.
Infectious disease assessment is part of safe pregnancy care, although it does not determine candidacy by itself. Broader perinatal discussions about screening and prevention, such as these group B streptococcus updates, illustrate why local protocols and current obstetric guidance matter when planning delivery after fetal intervention.
Counseling must include realistic alternatives: standard neonatal closure, pregnancy continuation with postnatal treatment, and, where legally and clinically relevant, other reproductive options. A balanced discussion explains expected neurological benefit, the possibility of no functional improvement, maternal risks, hospitalization, restrictions after surgery, and implications for future pregnancies.
Open fetal repair generally involves a maternal abdominal incision and a controlled opening of the uterus so surgeons can close the fetal spinal defect. Anesthesia, uterine relaxation, fetal monitoring, ultrasound guidance, and coordinated neonatal and neurosurgical planning are required. The mother typically remains under close observation afterward because contractions, membrane rupture, bleeding, and infection can lead to urgent delivery.
Fetoscopic methods use small ports and specialized instruments to close the lesion while minimizing the size of the uterine opening. These approaches may reduce maternal abdominal trauma and could improve reproductive outcomes, but they present technical challenges, including maintaining adequate visualization, achieving a durable watertight closure, and managing membrane separation or premature rupture.
Monitoring does not end when the operation is complete. Serial ultrasound evaluates ventricular size, amniotic fluid, fetal growth, placental position, and signs of membrane complications. Fetal well-being may be assessed through heart-rate surveillance and other methods appropriate to gestational age. Research into fetal oxygen monitoring is relevant to the wider goal of detecting compromise early in high-risk pregnancies, although no single monitoring technology eliminates the need for clinical judgment.
Delivery planning usually takes place at a tertiary center with neonatal intensive care, pediatric neurosurgery, maternal-fetal medicine, and anesthesia expertise. After birth, the infant is examined for neurological function, the closure is assessed, and brain imaging tracks hydrocephalus and hindbrain anatomy. The timing of any shunt or other neurosurgical treatment depends on clinical findings rather than a fixed schedule.
The most visible endpoint in many studies is shunt placement, but families often value daily function more than a procedural statistic. Mobility, orthotic needs, hand function, continence, pain, learning, communication, and participation in school and community life provide a fuller picture. Prenatal repair may improve the likelihood of walking or reduce the need for a shunt, yet many children still require extensive support.
Bladder and bowel dysfunction remains common because the spinal lesion affects the nerves controlling the lower urinary and gastrointestinal tracts. Regular urology follow-up, renal surveillance, catheterization when needed, bowel programs, and continence support can protect health and improve independence. Orthopedics and rehabilitation address hip displacement, scoliosis, contractures, muscle imbalance, and the practical use of mobility devices.
Hydrocephalus can evolve even when a shunt is not placed in infancy. Symptoms such as vomiting, headache, visual changes, lethargy, or declining school performance require prompt evaluation. Tethered cord, syringomyelia, scoliosis, and recurrent Chiari-related problems may also emerge later, making long-term neurosurgical follow-up essential.
Developmental outcomes are influenced by prematurity, hydrocephalus, lesion level, seizures, sleep, hearing and vision, family support, and access to therapy. Formal neuropsychological assessment can identify difficulties with attention, processing speed, executive skills, or mathematics before they become mistaken for poor motivation. A successful fetal operation is therefore the beginning of a care pathway, not its endpoint.
Families and clinicians can keep the discussion focused by reviewing the following points:
A center’s experience matters because outcomes depend on more than the operative technique. Case volume, anesthesia protocols, fetal monitoring, premature infant care, neonatal closure, rehabilitation access, and follow-up continuity all contribute to the result. Families should receive data from the specific program whenever possible rather than relying only on pooled international averages.
Research is also moving beyond the original trial questions. Investigators are studying less invasive closure, improved fetal imaging, biomarkers of neurological injury, placental and membrane complications, and standardized measures of participation and quality of life. Future comparisons will need to separate the effect of surgery from differences in selection, expertise, socioeconomic support, and lifelong access to specialized care.
Fetal surgery for spina bifida has produced a genuine shift in prenatal counseling: selected fetuses may gain improved early neurological and hydrocephalus-related outcomes, but the intervention carries serious maternal and obstetric costs. The best decisions come from transparent evidence, individualized imaging, careful risk assessment, and a commitment to decades of coordinated follow-up.
Specialist teams, researchers, and families can continue refining these pathways by sharing prospective outcomes, supporting long-term registries, and evaluating both physical function and lived experience. Use the available evidence and multidisciplinary consultation to make a timely, informed plan for each pregnancy.